Mai Capital Management Adma Biologics, Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mai Capital Management holds 50 shares of ADMA stock, worth $1,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$1,021% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
379Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$381 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$344 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$263 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$234 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$116 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.01B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...